RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, will be presenting at the Roth 22nd Annual Growth Stock Conference. The Conference will take place March 15 – 17, 2010 at the Ritz-Carlton Laguna Niguel, CA.
